Navigation Links
Boon for IVD Market Seen in Brisk Financing Activity
Date:6/30/2017

ROCKVILLE, Md., June 30, 2017 /PRNewswire/ -- In vitro diagnostics market firm Kalorama Information has notes that since the start of May, at least ten diagnostic companies have successfully completed financings.  The types of financings include private investments, public offerings and a loan facility.  The size of these financings ranged from approximately $3.3 million to almost $80 million.  Kalorama Information provides a monthly IVD Market Trends Report to customers of its Diagnostics Knowledge Center.

"Diagnostics deals are not large by nature but there has been a good amount of them," said Bruce Carlson, publisher of the New York City-based firm.  "They include companies developing and marketing in vitro diagnostic tests (kits), and also companies with laboratory developed tests (LDTs) that are offering testing services."

Disease areas include oncology, infectious diseases, genetic diseases, Alzheimer's disease, pharmacogenomics, and others.

Some financing includes the following:

  • Accelerate Diagnostics:  May 2017 announcement that the company had closed a previously announced underwritten public offering of common stock.  The offering had been upsized, and gross proceeds are approximately $79.3 million (before underwriting commissions and discounts, and before expenses).  Accelerate Diagnostics is an in vitro diagnostics company that is focused on antibiotic resistance and healthcare associated infections.

  • Akonni Biosystems:  May 2017 announcement that the company had raised $4 million in bridge financing.  Akonni Biosystems is a molecular diagnostics company.  At the time of the financing, the company reported that it is preparing an FDA submission for a clinical IVD pharmacogenomics test.

  • Arivale:  In June 2017, Arivale raised $13.6 million.  This is the first close of a planned $30 million investment round.  Arivale, which was co-founded by Leroy Hood and Clayton Lewis, is focused on wellness and personalized health management.  This includes a genetic analysis and other diagnostic tests.

  • Centogene:  June 2017 announcement that the company had raised €25 million in a Series A financing.  Centogene specializes in genetic testing of rare diseases.  The company plans to expand its services in genetic testing, pharmaceutical collaborations, and big-data solutions, and also to increase its presence in the United States and China.

  • Cytox:  June 2017 announcement that the company raised £2.6 million in new financing.  Cytox plans to use these funds to launch a predictive testing service for Alzheimer's disease.

  • GenMark Diagnostics:  June 2017 announcement that the company had increased the size of a previously announced public offering.  Gross proceeds are expected to be about $75 million.  GenMark markets automated multiplex molecular diagnostic platforms.

  • Interpace Diagnostics:  In June 2017, Interpace Diagnostics closed a public offering, raising net proceeds of $12.2 million.  Interpace Diagnostics offers molecular tests to help risk stratify thyroid and pancreatic cancer through the company's CLIA laboratories.

  • Novacyte Group:  June 2017 announcement that the company completed a €3 million private financing.  Novacyte Group offers tests and (through Lab 21) testing services, specializing in cancer and infectious diseases.

  • Stat-Dx:  At the beginning of June 2017, it was announced that Stat-Dx had secured a €20 million loan facility from the European Investment Bank.  The company is developing molecular diagnostic tests for pathogens.

  • Theradiag:  May 2017 announcement that the company had raised more than €4 million after issuing shares to "a specific category of persons."  The announcement reported that the funds would "enable Theradiag to facilitate and step up its international development and the marketing of its auto-immunity, allergy and theranostics products."

Combined, these ten companies have raised over $240 million since early May 2017.

Kalorama Information's Diagnostic Knowledge Center is a private content offering the firm makes to select clients to access its entire library of reports.   Information about Knowledge Center is available at: https://www.kaloramainformation.com/Content/Knowledge-Center-Information.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.  

Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.

Press Contact:
Bruce Carlson
212 807 2262     
bcarlson@marketresearch.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boon-for-ivd-market-seen-in-brisk-financing-activity-300482498.html


'/>"/>
SOURCE Kalorama Information
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
3. North America Home Healthcare Market Worth $130.4 Billion by 2017
4. TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace
5. Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth
6. Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market
7. Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets
8. Global Markets and Technologies for Optical Coherence Tomography (OCT)
9. Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace
10. China Pharmaceutical Market Guidebook Series (4) 2013 Report
11. Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalDatas 700 Market Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):